S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
NASDAQ:SIBN

SI-BONE (SIBN) Stock Price, News & Analysis

$15.23
-0.11 (-0.72%)
(As of 04/17/2024 ET)
Today's Range
$15.23
$15.68
50-Day Range
$14.97
$21.58
52-Week Range
$14.84
$29.51
Volume
276,788 shs
Average Volume
333,545 shs
Market Capitalization
$625.34 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$26.67

SI-BONE MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
75.1% Upside
$26.67 Price Target
Short Interest
Bearish
5.94% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-1.44
Upright™ Environmental Score
News Sentiment
0.00mentions of SI-BONE in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$185,285 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.98) to ($0.76) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.19 out of 5 stars

Medical Sector

173rd out of 913 stocks

Surgical & Medical Instruments Industry

24th out of 89 stocks

SIBN stock logo

About SI-BONE Stock (NASDAQ:SIBN)

SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

SIBN Stock Price History

SIBN Stock News Headlines

SI-BONE (NASDAQ:SIBN) Reaches New 1-Year Low at $14.84
Did You Get Your Free Bitcoin Yet?
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
Peeling Back The Layers: Exploring SI-BONE Through Analyst Insights
SIBN Apr 2024 2.500 put
Did You Get Your Free Bitcoin Yet?
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
SIBN Jul 2024 10.000 put
When Will SI-BONE, Inc. (NASDAQ:SIBN) Become Profitable?
SI-BONE Shares Drop 14% Following 4Q Loss
Beyond The Numbers: 4 Analysts Discuss SI-BONE Stock
SI-BONE earnings: here's what to expect
What Analysts Are Saying About SI-BONE Stock
See More Headlines
Receive SIBN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SI-BONE and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/26/2024
Today
4/17/2024
Next Earnings (Confirmed)
5/06/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:SIBN
Fax
N/A
Employees
344
Year Founded
2008

Price Target and Rating

Average Stock Price Target
$26.67
High Stock Price Target
$33.00
Low Stock Price Target
$24.00
Potential Upside/Downside
+75.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

Net Income
$-43,340,000.00
Pretax Margin
-31.20%

Debt

Sales & Book Value

Annual Sales
$138.89 million
Book Value
$4.18 per share

Miscellaneous

Free Float
38,847,000
Market Cap
$625.34 million
Optionable
Optionable
Beta
1.20

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives


SIBN Stock Analysis - Frequently Asked Questions

Should I buy or sell SI-BONE stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for SI-BONE in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" SIBN shares.
View SIBN analyst ratings
or view top-rated stocks.

What is SI-BONE's stock price target for 2024?

5 Wall Street research analysts have issued 12-month target prices for SI-BONE's shares. Their SIBN share price targets range from $24.00 to $33.00. On average, they predict the company's share price to reach $26.67 in the next twelve months. This suggests a possible upside of 75.1% from the stock's current price.
View analysts price targets for SIBN
or view top-rated stocks among Wall Street analysts.

How have SIBN shares performed in 2024?

SI-BONE's stock was trading at $20.99 on January 1st, 2024. Since then, SIBN stock has decreased by 27.4% and is now trading at $15.23.
View the best growth stocks for 2024 here
.

When is SI-BONE's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 6th 2024.
View our SIBN earnings forecast
.

How can I listen to SI-BONE's earnings call?

SI-BONE will be holding an earnings conference call on Monday, May 6th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How were SI-BONE's earnings last quarter?

SI-BONE, Inc. (NASDAQ:SIBN) released its earnings results on Monday, February, 26th. The company reported ($0.27) EPS for the quarter, topping the consensus estimate of ($0.29) by $0.02. The company had revenue of $38.86 million for the quarter, compared to analyst estimates of $38.60 million. SI-BONE had a negative trailing twelve-month return on equity of 28.22% and a negative net margin of 31.20%.

What guidance has SI-BONE issued on next quarter's earnings?

SI-BONE updated its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $162.0 million-$165.0 million, compared to the consensus revenue estimate of $159.1 million.

What is Jeffrey Dunn's approval rating as SI-BONE's CEO?

10 employees have rated SI-BONE Chief Executive Officer Jeffrey Dunn on Glassdoor.com. Jeffrey Dunn has an approval rating of 41% among the company's employees. This puts Jeffrey Dunn in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of SI-BONE own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SI-BONE investors own include CVS Health (CVS), Home Depot (HD), Procter & Gamble (PG), RTX (RTX), Thermo Fisher Scientific (TMO), Verizon Communications (VZ), Alibaba Group (BABA), Cisco Systems (CSCO) and CSX (CSX).

When did SI-BONE IPO?

SI-BONE (SIBN) raised $84 million in an initial public offering (IPO) on Wednesday, October 17th 2018. The company issued 6,000,000 shares at $13.00-$15.00 per share. Morgan Stanley and BofA Merrill Lynch acted as the underwriters for the IPO and Canaccord Genuity and JMP Securities were co-managers.

How do I buy shares of SI-BONE?

Shares of SIBN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does SI-BONE have any subsidiaries?
The following companies are subsidiares of SI-BONE: SI-BONE Deutschland GmbH, SI-BONE S.R.L., and SI-BONE UK LTD.
Read More
This page (NASDAQ:SIBN) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners